保留假体的保乳头乳房切除术:回顾性队列研究
该回顾性队列研究比较了既往隆乳患者的保乳头保假体乳房切除术(NISM)与保乳头乳房切除术(NSM)的并发症率。结论认为NISM并发症率更低,是安全可行的新选择。
要点
- NISM组总体并发症率20%,低于NSM组的27%。
- 两组并发症差异无统计学意义(OR 0.54,95%CI 0.18-1.64,P=0.278)。
- NISM对既往假体隆乳的乳腺癌患者是可行且安全的选择。
核心结论
- NISM的总体并发症率低于NSM,但差异未达统计学显著。
- NISM是既往肌下假体隆乳乳腺癌患者的一种新颖、可行且安全的选择。
研究设计与样本
- 收集年龄、肿瘤大小、分级、受体状态及乳房切除至假体置换间隔等数据。
主要发现
- NISM组总体并发症率为20%,NSM组为27%。
- logistic回归显示并发症与手术类型的OR为0.54(95%CI 0.18-1.64,P=0.278)。
关键数值与推荐
- 总体并发症率NISM 20% vs NSM 27%。
- OR 0.54(95%CI 0.18-1.64),P=0.278。
临床怎么用
- 对既往假体隆乳的乳腺癌患者,可考虑NISM以保留假体。
- 需个体化评估,与患者充分沟通NISM的潜在获益与风险。
局限性
- 回顾性设计可能存在选择偏倚。
- 并发症差异未达统计学显著,需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mastectomies are an integral part of breast cancer treatment for many patients.1 Of those patients, a significant number have previously undergone breast augmentation before being diagnosed with breast cancer. Therefore, we developed the novel technique of performing nipple- and implant-sparing mastectomies (NISMs) for women with prior breast augmentations. This study will assess the plausibility of using NISMs versus nipple-sparing mastectomies (NSMs) in this subgroup of patients by comparing the complication rates. METHODS: Data were collected on age, tumor size, tumor grade, receptors, and the interval between mastectomy and implant exchange for both groups. Descriptive statistics were used to summarize patient characteristics. Independent samples t tests, χ2 tests, and Fisher exact tests were used to compare the NISM and NSM cohorts. Logistic regression was used to assess the association between complications and mastectomy type and was summarized as an odds ratio with a 95% confidence interval. RESULTS: Fifteen patients underwent an NISM and 35 patients underwent an NSM. The overall rate of complications was less in NISM cases than in NSM cases (20% vs 27%). However, this difference was not statistically significant (odds ratio, 0.54; 95% confidence interval, 0.18-1.64; P = 0.278). CONCLUSIONS: The overall complication rate was lower with NISMs compared with NSMs. Nipple- and implant-sparing mastectomy is a novel, viable, and safe option for patients with breast cancer and a history of submuscular breast augmentation.
引用
- Le NK, Soni SE, Smith PD, et al. Preservation of the Implant in Nipple-Sparing Mastectomies: A Retrospective Cohort Study. Ann Plast Surg. 2021. PMID: 33538504. doi:10.1097/SAP.0000000000002696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。